Patents Assigned to Jura Bio, Inc.
  • MAJOR HISTOCOMPATIBILITY COMPLEX-BASED CHIMERIC RECEPTORS AND USES THEREOF FOR TREATING AUTOIMMUNE DISEASES
    Publication number: 20240165158
    Abstract: Major histocompatibility complex-based chimeric receptors (MHC-CAR) for use in targeting autoreactive immune cells. Also provided herewith are genetically engineered immune cells expressing the MHC-CAR for use in treating autoimmune diseases such as multiple sclerosis.
    Type: Application
    Filed: October 19, 2023
    Publication date: May 23, 2024
    Applicant: Jura Bio, Inc.
    Inventors: Julie Norville, Elizabeth Wood
  • Major histocompatibility complex-based chimeric receptors and uses thereof for treating autoimmune diseases
    Patent number: 11826385
    Abstract: Major histocompatibility complex-based chimeric receptors (MHC-CAR) for use in targeting autoreactive immune cells. Also provided herewith are genetically engineered immune cells expressing the MHC-CAR for use in treating autoimmune diseases such as multiple sclerosis.
    Type: Grant
    Filed: November 10, 2018
    Date of Patent: November 28, 2023
    Assignee: Jura Bio, Inc.
    Inventors: Julie Norville, Elizabeth Wood
  • MAJOR HISTOCOMPATIBILITY COMPLEX-BASED CHIMERIC RECEPTORS AND USES THEREOF FOR TREATING AUTOIMMUNE DISEASES
    Publication number: 20210169929
    Abstract: Major histocompatibility complex-based chimeric receptors (MHC-CAR) for use in targeting autoreactive immune cells. Also provided herewith are genetically engineered immune cells expressing the MHC-CAR for use in treating autoimmune diseases such as multiple sclerosis.
    Type: Application
    Filed: November 10, 2018
    Publication date: June 10, 2021
    Applicant: Jura Bio, Inc.
    Inventors: Julie Norville, Elizabeth Wood